Fingerprint
Dive into the research topics of 'Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668
Joel M. Reid, Chad A. Walden, Rui Qin, Katie L. Allen Ziegler, John L. Haslam, Roger A. Rajewski, Roger Warndahl, Cindy L. Fitting, Daniel Boring, Eva Szabo, James Crowell, Marjorie Perloff, Ling Jong, Brent A. Bauer, Sumithra J. Mandrekar, Matthew M. Ames, Paul J. Limburg
Research output: Contribution to journal › Article › peer-review
26
Scopus
citations